Dr. Samuel Kim, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,275 | 3 | 78.1% |
| Food and Beverage | $1,957 | 61 | 18.5% |
| Travel and Lodging | $333.16 | 2 | 3.1% |
| Education | $27.86 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $8,275 | 3 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $711.98 | 5 | $0 (2022) |
| Genentech USA, Inc. | $330.61 | 12 | $0 (2024) |
| ABBVIE INC. | $292.75 | 12 | $0 (2024) |
| Alcon Vision LLC | $222.00 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $171.96 | 7 | $0 (2023) |
| Allergan, Inc. | $135.59 | 7 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $86.85 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $79.85 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $61.27 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $305.48 | 7 | Alcon Vision LLC ($149.68) |
| 2023 | $2,884 | 23 | Stryker Corporation ($2,275) |
| 2022 | $1,045 | 19 | Biohaven Pharmaceutical Holding Company Ltd. ($711.98) |
| 2021 | $6,114 | 7 | Stryker Corporation ($6,000) |
| 2020 | $40.53 | 2 | Regeneron Healthcare Solutions, Inc. ($27.86) |
| 2019 | $83.78 | 4 | Allergan Inc. ($58.86) |
| 2018 | $120.18 | 5 | Orthofix Medical, Inc. ($43.37) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: EYE CARE | ||||||
| 07/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Ophthalmology | ||||||
| 06/21/2024 | Alcon Vision LLC | Wavelight Refractive Suite (Device) | Food and Beverage | In-kind items and services | $149.68 | General |
| Category: Ophthalmology | ||||||
| 02/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/01/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: EYE CARE | ||||||
| 12/04/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: EYE CARE | ||||||
| 11/27/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $12.94 | General |
| 11/07/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Ophthalmology | ||||||
| 11/01/2023 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: DIAGNOSTICS | ||||||
| 10/02/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/27/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: EYE CARE | ||||||
| 09/25/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $18.54 | General |
| 08/27/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $20.41 | General |
| 07/31/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Ophthalmology | ||||||
| 07/24/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/19/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: EYE CARE | ||||||
| 05/10/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: EYE CARE | ||||||
| 05/08/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $72.32 | General |
| Category: Ophthalmology | ||||||
| 05/03/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $34.18 | General |
| Category: Ophthalmology | ||||||
| 04/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/21/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/13/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,034 | 18,789 | $4.3M | $1.5M |
| 2022 | 13 | 2,293 | 8,594 | $4.3M | $1.5M |
| 2021 | 12 | 2,026 | 7,326 | $4.2M | $1.5M |
| 2020 | 14 | 2,092 | 7,271 | $4.1M | $1.4M |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 105 | 973 | $1.2M | $668,941 | 54.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 42 | 12,123 | $772,600 | $352,519 | 45.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 630 | 1,683 | $235,620 | $155,286 | 65.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 243 | 993 | $1.5M | $100,977 | 6.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 14 | 322 | $79,000 | $50,260 | 63.6% |
| 92134 | Imaging of retina | Office | 2023 | 515 | 1,422 | $234,630 | $45,426 | 19.4% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 11 | 316 | $81,100 | $38,034 | 46.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 105 | 397 | $39,700 | $22,346 | 56.3% |
| 92250 | Photography of the retina | Office | 2023 | 275 | 427 | $48,678 | $12,389 | 25.5% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 16 | 22 | $48,312 | $5,962 | 12.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 36 | 66 | $7,820 | $4,423 | 56.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 14 | 14 | $2,926 | $1,379 | 47.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,244 | $1,108 | 49.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 17 | 20 | $7,200 | $677.66 | 9.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 134 | 1,394 | $1.7M | $1.0M | 57.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 721 | 1,883 | $263,620 | $176,975 | 67.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 283 | 1,160 | $1.7M | $116,125 | 6.9% |
| 92134 | Imaging of retina | Office | 2022 | 699 | 1,968 | $324,720 | $64,642 | 19.9% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 11 | 245 | $61,250 | $38,676 | 63.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 151 | 577 | $57,700 | $31,208 | 54.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 12 | 1,020 | $64,600 | $30,438 | 47.1% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 29 | 35 | $76,860 | $9,597 | 12.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 45 | 48 | $16,992 | $5,026 | 29.6% |
| 92250 | Photography of the retina | Office | 2022 | 122 | 156 | $17,784 | $4,450 | 25.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 49 | 62 | $6,200 | $4,227 | 68.2% |
About Dr. Samuel Kim, MD
Dr. Samuel Kim, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Upland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1720379100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Kim, MD has received a total of $10,593 in payments from pharmaceutical and medical device companies, with $305.48 received in 2024. These payments were reported across 67 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($8,275).
As a Medicare-enrolled provider, Kim has provided services to 8,445 Medicare beneficiaries, totaling 41,980 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Retina Specialist, Ophthalmology
- Location Upland, CA
- Active Since 04/20/2011
- Last Updated 06/24/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720379100
Products in Payments
- YUKON OCT SPINAL SYSTEM (Device) $5,275
- AVS ANCHOR-C (Device) $3,000
- NURTEC ODT (Drug) $711.98
- OZURDEX (Drug) $339.14
- Vabysmo (Drug) $198.29
- EYLEA (Biological) $171.96
- Wavelight Refractive Suite (Device) $149.68
- XIPERE (Drug) $86.85
- VABYSMO (Drug) $81.24
- Clareon (Device) $72.32
- Syfovre (Drug) $61.27
- LUMIGAN (Drug) $55.70
- All Spine Stimulation (Biological) $43.37
- OXERVATE (Drug) $32.67
- Izervay (Drug) $27.96
- TRAVATAN Z (Drug) $24.92
- Rhopressa (Drug) $24.39
- SUSVIMO (Drug) $21.95
- WaveWriter Alpha Prime 16 (Device) $19.23
- Cequa (Drug) $18.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Upland
Anthony Turk, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $7,390
Cecilia Phong, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $6,255
Dr. Chang Sup Lee, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $5,248
Dr. Brenna Sommer, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $5,177
Dr. Dhaval Patel, D.p.m, D.P.M
Student in an Organized Health Care Education/Training Program — Payments: $4,670
Kishore Jayakumar
Student in an Organized Health Care Education/Training Program — Payments: $1,771